Budesonide Suspension
Product Images NDC 55154-4849

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 55154-4849). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

D8bb0fbc 3b34 45b1 91d1 Fd7b810873a4 00

This is a description of a medication called Budesonide Inhalation Suspension. The medication comes in vials, each containing 2mL of sterile suspension with 0.5g of micronized budesonide. It is intended for oral inhalation use only, not injection. The vials should be stored in a cool, dry place and used immediately after opening. The medication is administered using an ultrasonic nebulizer. A full prescribing information, precautions, and warnings are included in the product insert. The medication is manufactured in England by Noron Healthcare Limited and is distributed in the US by Cardinal Health.*

FDA Label Image

Chemical Structure For Budesonide (Image 1)

FDA Label Image

Figure 1: A 12 Week Trial In Pediatric Patients (Image 2)

FDA Label Image

Figure 2: A 12-week Trail In Pediatric Patients (Image 3)

This appears to be a medical study evaluating the effectiveness of a medication for nighttime asthma symptoms. The medication is compared to a placebo and different dosages are administered. The results are shown in a table, indicating p-values for the different doses.*

FDA Label Image

Figure 3: A 12-week Trail In Pediatric (Image 4)

FDA Label Image

1 (Image 5)

FDA Label Image

1 (Image 6)

FDA Label Image

1 (Image 7)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.